December 8, 2016
Hair care company places shares, raises half million
InnovaDerma, a UK -based company focused on hair loss, hair care, self-tanning and skin rejuvenation, has raised £539,999.60 through the…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Business
December 8, 2016
Bayer buys BIVI’s animal health products in US
Bayer and Boehringer Ingelheim Vetmedica, Inc. (BIVI) have made a deal for Bayer to buy BIVI’s Cydectin bovine and ovine…
December 7, 2016
Eselior names Laurent Vahcerot president and COO
Essilor, a medical supplies company, has decided to realign its organization to meet the growing operational needs as the company…
December 2, 2016
Amryt loans from EIB for skin disorder gel aimed for $1.5 billion market
Amryt, the clinical-stage specialty pharmaceutical company focused on fighting rare and orphan diseases, has raised a five-year €20m loan with…
November 10, 2016
Allergan announces launch of birth control capsules
Allergan has announced the availability of TAYTULLATM (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules)…
November 10, 2016
BD and JDRF join forces to fight type 1 diabetes
BD has announced a new research collaboration supported by JDRF, the global organization funding…
November 10, 2016
Lifeline Scientific leaves AIM due to merger with Shanghai Genext
The merger of Lifeline Scientific with Shanghai Genext Medical Technology and certain of its affiliates dated September 1, 2016, is…
November 10, 2016
Bristol-Myers to develop Nitto's investigational anti-fibrosis drug
Bristol-Myers gets exclusive worldwide rights to develop Nitto’s investigational anti-fibrosis drug
November 10, 2016
Comprehensive loss for Probiodrug in the third quarter of 2016
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing therapeutic solutions to treat Alzheimer’s disease, has finished the third quarter 2016…
November 10, 2016
Catalyst Pharmaceuticals finishes Q3 2016 with net loss
Catalyst Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating …